CHI Memorial announces it is the first in the Chattanooga region to offer Aquablation therapy for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH), or ...
G_enlarged prostate_BPH Randomized trial reveals no significant difference between Aquablation and TURP in improvements in lower urinary tract symptoms, peak urinary flow, and post-void residual ...
SAN JOSE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (PRCT) ® Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative ...
SAN JOSE, Calif., March 23, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® (Nasdaq: PRCT) today highlighted the latest update to the European Association of Urology (EAU) Guidelines for male lower ...
PROCEPT BioRobotics announced positive WATER III trial results for Aquablation therapy in large prostates, showing effective outcomes and reduced complications. PROCEPT BioRobotics Corporation ...
SAN JOSE, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT), today announced the international expansion of the HYDROS Robotic System, the company’s next-generation ...
SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through ...
Add Yahoo as a preferred source to see more of our stories on Google. Consultant Urologist, Mr Tim Dudderidge alongside the Aquablation® Therapy robot. (Image: Spire Southampton Hospital) Spire ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--PROCEPT BioRobotics Corporation, a surgical robotics company developing intelligent solutions to transform the field of urology, has announced that the safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results